Richard Barrett

Co-Founder, CSO @ Guardian Bio arrow icon

About Richard Barrett

Richard Barrett is the Co-Founder and Chief Scientific Officer who began his career as a marine biologist and research diver, later focusing on immunology and cancer research.

Known information

Richard Barrett is the Co-Founder and Chief Scientific Officer (CSO). He started his career as a marine biologist and research diver at Florida Atlantic University, where he focused on marine natural products and drug discovery. He pursued a PhD in immunology at the University of Central Florida and completed a postdoctoral fellowship in cancer immunology and tumor microenvironment at the University of Pennsylvania. During his postdoctoral fellowship, he worked on academic and industry partnerships, published papers, and received academic grants, including the Ruth L. Kirschstein National Research Service Award (T32). Barrett is also a prolific science communicator, frequently appearing on podcasts and creating educational science content for an audience of over a quarter million followers across various social media platforms.

About Guardian Bio

Guardian Bio, based in Boston, MA, is a healthcare company specializing in therapeutics, focusing on developing dendritic cell-based therapies to enhance anti-tumor activity.

report flag Report inaccurate information

People similar to Richard Barrett

Ananya Zutshi is the Co-Founder and CEO with a background in Biomedical Engineering from Duke University and advanced degrees from Harvard. She has extensive experience in the pharma/biotech industry, focusing on operations, engineering, business development, and project management.

Ivana Djuretic

Founder, Chief Scientific Officer @ Asher Bio

Ivana Djuretic is a distinguished immunologist and entrepreneur, known for co-founding Asher Bio and her leadership in cytokine biology and cell therapy programs.

Nate Fernhoff

Co-founder and Team Lead Science @ Orca Bio

Nate Fernhoff, PhD, is a co-founder and the Team Lead Science at Orca-Q, known for his contributions to high-precision cell therapy for high-risk blood diseases.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free